Markers of hypercoagulability in cancer patients

Research output: Contribution to journalArticle

Abstract

In the last few years, several assays have been developed that permit the evaluation, with a high degree of sensitivity, of the level of activation of the coagulation system. Some of these tests have been used in cancer patients, in an attempt to monitor the risks of tumour progression and the development of thromboembolic complications. Even though coagulation activation markers are often abnormally elevated, the results available so far do not indicate that they are useful in the clinical management of individual cancer patients.

Original languageEnglish
Pages (from-to)25-31
Number of pages7
JournalHaemostasis
Volume27
Issue numberSUPPL. 1
Publication statusPublished - Nov 1997

    Fingerprint

Keywords

  • Cancer
  • Coagulation activation
  • Hypercoagulability

ASJC Scopus subject areas

  • Hematology

Cite this